Loading...
XASXBPH
Market cap8mUSD
Jan 02, Last price  
0.01AUD
1D
0.00%
1Q
-15.38%
Jan 2017
-66.18%
Name

BPH Energy Ltd

Chart & Performance

D1W1MN
XASX:BPH chart
P/E
2.94
P/S
15.88
EPS
0.00
Div Yield, %
0.00%
Shrs. gr., 5y
37.53%
Rev. gr., 5y
24.84%
Revenues
844k
+177.48%
010,000436,1831,063,617134,335164,645138,5250301,808265,663224,420181,758216,925235,824278,227240,24365,50568,143304,054843,683
Net income
5m
+433.96%
0-997,022-1,275,517-1,160,864-2,215,717-208,785-220,903-739,165-568,454-1,253,563-26,487,710-509,457-636,874-1,505,840-3,012,7981,121,801-1,611,859-1,078,448853,4264,556,970
CFO
-942k
L-10.38%
00000000-412,426-400,388-424,043-218,606-517,680-466,968-487,427-504,295-703,808-1,022,124-1,050,582-941,509
Earnings
Feb 26, 2025

Profile

BPH Energy Limited invests in biotechnology, oil and gas exploration and development, and medicinal cannabis industries in Australia. The company is building a system to generate clean hydrogen and conductive carbon used to manufacture batteries for commercial use. It also offers brain anaesthesia response monitoring system, a device to detect the effect of anaesthetic agents on brain activity and assist anaesthetists in keeping patients optimally anaesthetised. In addition, the company invests in the biomedical research of HLS5 tumour suppressor gene for liver cancer. Further, it holds a 100% interest in RL1 oil and gas assets located in the onshore Bonaparte basin in northern Australia; and 85% interest in the petroleum exploration permit 11 asset situated in the offshore Sydney basin. The company was formerly known as BioPharmica Limited. BPH Energy Limited was incorporated in 2001 and is headquartered in Stirling, Australia.
URL
https://www.bphenergy.com.au/
IPO date
Aug 06, 2004
Employees
2,000
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
844
177.48%
304
346.20%
68
4.03%
Cost of revenue
1,716
1,712
913
Unusual Expense (Income)
NOPBT
(872)
(1,407)
(845)
NOPBT Margin
Operating Taxes
(257)
(1,216)
(285)
Tax Rate
NOPAT
(615)
(191)
(560)
Net income
4,557
433.96%
853
-179.13%
(1,078)
-33.09%
Dividends
Dividend yield
Proceeds from repurchase of equity
4,806
4,004
1
BB yield
-25.80%
-20.70%
-0.02%
Debt
Debt current
85
88
105
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(23,835)
(18,948)
(14,947)
Cash flow
Cash from operating activities
(942)
(1,051)
(1,022)
CAPEX
Cash from investing activities
(3,053)
(217)
(6,258)
Cash from financing activities
4,803
3,987
1
FCF
(3,127)
(655)
(560)
Balance
Cash
6,445
5,636
2,917
Long term investments
17,474
13,400
12,135
Excess cash
23,877
19,021
15,048
Stockholders' equity
29,300
19,412
14,300
Invested Capital
5,508
479
105
ROIC
ROCE
EV
Common stock shares outstanding
1,034,762
840,778
677,433
Price
0.02
-21.74%
0.02
109.09%
0.01
-84.51%
Market cap
18,626
-3.68%
19,338
159.51%
7,452
-47.93%
EV
(5,373)
227
(7,656)
EBITDA
(872)
(1,407)
(845)
EV/EBITDA
6.16
9.06
Interest
54
309
105
Interest/NOPBT